Related Experiment Video
Updated: Jun 24, 2026

14:40
Expression Analysis of Mammalian Linker-histone Subtypes
Published on: March 19, 2012
Complete array of HOX gene expression by RQ-PCR
Glenda J Dickson1, Terence R Lappin, Alexander Thompson
1Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, Ireland. g.mcgonigle@qub.ac.uk
Methods in Molecular Biology (Clifton, N.J.)
|March 12, 2009
Summary
HOX genes regulate development and hematopoiesis. Measuring HOX gene expression via real-time quantitative PCR (RQ-PCR) aids leukemia research and potential therapeutic targets.
Area of Science:
- Developmental Biology
- Molecular Biology
- Cancer Genetics
Background:
- The HOX gene network comprises 39 genes crucial for mammalian development, including hematopoiesis.
- Chromosomal translocations in acute leukemias often involve HOX genes or regulatory factors like MLL, causing aberrant gene expression.
- HOX genes share high sequence similarity, particularly in the homeobox domain, due to evolutionary duplication.
Purpose of the Study:
- To establish a precise method for quantifying HOX gene expression (the HOXOME).
- To investigate the role of HOX genes in hematopoiesis and leukemia.
- To identify potential therapeutic targets for leukemia.
Main Methods:
- Utilized real-time quantitative PCR (RQ-PCR) with Taqman probe chemistry.
- Developed carefully selected reagents for specific HOX gene quantification.
- Applied the platform to measure individual human and murine HOX genes.
Main Results:
- Demonstrated the value of RQ-PCR with Taqman chemistry for precise HOX gene measurement.
- Achieved high specificity and a wide dynamic range in quantifying HOX gene expression.
- Established a reliable method for analyzing the HOXOME.
Conclusions:
- Quantifying HOX gene expression is feasible and precise using RQ-PCR.
- Understanding HOX gene roles in hematopoiesis is key to elucidating leukemia mechanisms.
- This research may lead to novel therapeutic strategies for leukemia by targeting HOX gene deregulation.

